Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-10T06:18:54.943Z Has data issue: false hasContentIssue false

Elevated pulse pressure and its associations with demographic and clinical parameters in a clinically representative sample of outpatients with psychotic disorders

Published online by Cambridge University Press:  07 April 2022

Christopher Holmberg*
Affiliation:
Department of Psychotic Disorders, Sahlgrenska University Hospital, and Department of Health and Care Sciences, University of Gothenburg, Gothenburg, Sweden
Jarl Torgerson
Affiliation:
Department of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, Sweden
Andreas Gremyr
Affiliation:
Department of Psychotic Disorders, Sahlgrenska University Hospital, Gothenburg, and Jönköping Academy for Improvement of Health and Welfare, Jönköping University, Jönköping, Sweden
*
Correspondence: Christopher Holmberg. Email: christopher.holmberg@gu.se
Rights & Permissions [Opens in a new window]

Abstract

Elevated pulse pressure is associated with metabolic and neurocognitive diseases. Preliminary small-scale studies among patients with psychotic disorders have indicated that these patients had an increased pulse pressure compared with controls. However, it is unclear whether and how these associations are manifested among larger heterogenous samples of patients with psychotic disorders. We examined elevated pulse pressure and its associations with demographic and clinical characteristics in a clinically representative sample of outpatients with psychotic disorders (n = 1289). In a subsample (n = 343), we also examined associations with six domains of functioning. Controlling for age and cardiovascular disease, body mass index (BMI) and employment status independently predicted the odds ratio of having elevated pulse pressure. Elevated pulse pressure was also primarily associated with the physical domains of functioning. Outpatients with psychotic disorders that have high BMI and are unemployed thus seem to be at increased risk for elevated pulse pressure and should therefore be particularly considered for blood pressure screenings.

Type
Short report
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists

Pulse pressure, defined as the difference between systolic and diastolic blood pressure, generally increases with age owing to changes in arterial elasticity and reflects physiological ageing of the cardiovascular system.Reference Nawrot, Staessen, Thijs, Fagard, Tikhonoff and Wang1 The European Society of Hypertension has recognised widened pulse pressure as a distinct risk factor that is separate from elevated systolic blood pressure.Reference Mansia, De Backer, Dominiczak, Cifkova, Fagard and Germano2

Elevated pulse pressure has also been associated with insulin resistance, all-cause mortality among older adults, cardiovascular disease (CVD) and kidney disease.Reference Dart and Kingwell3 Elevated pulse pressure can cause blood–brain barrier dysfunction and subsequent adverse neurological changes that may drive or contribute to cognitive impairment not only among older persons.Reference Thorin-Trescases, de Montgolfier, Pinçon, Raignault, Caland and Labbé4 Elevated pulse pressure dysregulates cerebral endothelial cells, leading to cerebral microvascular damage, along with excessive pulsatile force, which induces breakdown of the blood–brain barrier, resulting in brain cell impairment.Reference Levin, Carnegie and Celermajer5

In a small-scale study, patients with psychotic disorders (n = 41) were found to have an increased pulse pressure compared with controls.Reference Fernandez-Egea, Bernardo, Heaphy, Griffith, Parellada and Esmatjes6 Preliminary research has indicated that higher pulse pressure could predict the generalised cognitive deficit in psychotic disorders, confirming the role of metabolic abnormalities in the generalised cognitive deficit and suggesting that treatment of hypertension might be a novel adjunctive therapy target for remediating such deficits.Reference Morra and Strauss7

It is thus important to examine pulse pressure in larger clinically representative psychiatric samples. As blood pressure is routinely measured in most psychiatric settings, and pulse pressure is easily calculated, it could enable the prediction of cardiometabolic and cognitive factors. Furthermore, examining associations with demographic and clinical characteristics could help to identify patients at increased risk of elevated pulse pressure, such as those with reduced access to blood pressure screenings due to their socioeconomic status and functional impairments.Reference Jung, Choi, Park, Jang and Park8,Reference Matricciani, Paquet, Howard, Adams, Coffee and Taylor9

We therefore aimed to examine pulse pressure and its associations with demographic and clinical characteristics, and with several domains of functioning among outpatients with psychotic disorders.

Method

The Department of Psychotic Disorders at Sahlgrenska University Hospital in Gothenburg, Sweden, provides tertiary care for individuals with psychotic disorders. We used already-registered patient data, and ethical approval was obtained from the Swedish Ethical Review Authority (#2020–03010).

An observational cross-sectional study design was employed.Reference Vandenbroucke, von Elm, Altman, Gøtzsche, Mulrow and Pocock10 Data from annual outpatient check-ups, conducted by the patient's case manager and physician, were used. This included background information such as demographic information, and results from health check-ups (e.g. disease status). The primary criterion was that patients had completed an annual check-up that was recorded in the hospital quality register between 2016 and 2019. During this period, a total of 2179 patients had an annual check-up recorded; of these, 1289 patients had complete blood pressure and body mass index (BMI) measurements recorded within the same 7 day period as the annual check-up (Supplementary file 1 available at https://doi.org/10.1192/bjo.2022.52).

At a few outpatient units, we also had information about patients’ functioning, assessed using the 12 item World Health Organization Disability Assessment Schedule 2.0 (WHODAS-2.0), a self-administered questionnaire.Reference Holmberg, Gremyr, Torgerson and Mehlig11 This is a general assessment instrument that can be used in both patient and general population settings and has been cross-culturally validated both in patients with mental disorders and in those with somatic disorders.Reference Üstün, Chatterji, Kostanjsek, Rehm, Kennedy and Epping-Jordan12 The questionnaire contains two items corresponding to each domain of functioning (cognition, mobility, household, self-care, social and society), and the domains are directly linked to disability concepts according to the International Classification of Functioning, Disability and Health.Reference Üstün, Chatterji, Kostanjsek, Rehm, Kennedy and Epping-Jordan12 The Swedish version has been psychometrically validated in the patient population.Reference Holmberg, Gremyr, Torgerson and Mehlig11 Specifically, the Swedish instrument was validated against patients’ age, clinically diagnosed comorbidities, living conditions, antipsychotic treatment status and psychotic symptom severity.Reference Holmberg, Gremyr, Torgerson and Mehlig11 Of particular interest for this population and the current study, the previous validation study showed that patients who were rated low on psychotic symptom severity generally also self-assessed as having lower functional impairments.Reference Holmberg, Gremyr, Torgerson and Mehlig11 This indicates that the instrument accounts for psychotic symptomology.

Pulse pressure was used both as a continuous (mm/Hg) and a dichotomous variable. The threshold for elevated pulse pressure was set at ≥60 mm/Hg following the 2018 European Society of Cardiology guidelines.Reference Williams, Mancia, Spiering, Agabiti Rosei, Azizi and Burnier13 See Supplementary file 2 for all included variables.

Descriptive (e.g. frequencies and dispersions) and inferential statistics were used to examine the data. Both parametric and non-parametric statistical tests were applied depending on the distribution of data (i.e. normally, or non-normally distributed) and the variable type (e.g. interval level or ordinal). Normality was assessed using the Shapiro–Wilk test and complemented by evaluating histograms with normality curves to display the shape and spread of distributions. Thus, associations and differences were assessed using independent samples t-tests, χ²-tests, Mann–Whitney U-tests and Spearman's rho. Multiple linear regression analyses were used to assess how much of the variance (measured with adjusted R2) the significant independent variables accounted for with pulse pressure as a dependent variable. Finally, binary logistic regression analyses (enter method) were used to identify independent predictors of elevated pulse pressure (≥60 mm/Hg).

SPSS (v. 26, IBM) was used for all statistical analyses. P-values were defined with a two-tailed significance level at 0.05.

Results

A clinically representative sample of 1289 patients was obtained. The mean age was 52.2 (s.d. = 14.3, min–max: 19–92), 592 (46%) were female, the mean systolic blood pressure was 128.1 (s.d. = 16.7, min–max: 86–222), the mean diastolic blood pressure was 80.2 (s.d. = 10.9, min–max: 48–125) and the mean pulse pressure was 47.9 (s.d. = 13.8, min–max: 13–120). Most patients were on antipsychotic medication (91%) and had been diagnosed with a psychotic disorder for more than 10 years (75%).

Of all patients, 257 (20%) had elevated pulse pressure (≥60). Compared with patients with normal pulse pressure, patients with elevated pulse pressure were significantly older (mean age 58 v. 51 years, t = −7.9, P = <0.001), a higher proportion were diagnosed with psychotic disorder more than 10 years ago (81% v. 74%, X2 = 6.3, P = 0.012) and a lower proportion of patients had undergone a medical examination within a year (54% v. 63%, X2 = 7.5, P = 0.006).

Furthermore, patients with elevated pulse pressure had a higher prevalence of diabetes (22% v. 13%, X2 = 12.4, P = <0.001), chronic obstructive pulmonary disease (COPD) (7% v. 2%, X2 = 5.5, P = 0.019), CVD (25% v. 12%, X2 = 26.9, P = <0.001) and history of cancer (5% v. 2%, X2 = 5.7, P = 0.017).

Using Spearman's rho, statistically significant associations were found between pulse pressure and the following variables: age (r = 0.240, P = <0.001), female sex (r = 0.097, P = 0.001), BMI (r = 0.074, P = 0.008), CVD (r = 0.138, P = <0.001), diabetes (r = 0.094, P = 0.001), COPD (r = 0.061, P = 0.030), having been born in Sweden (r = −0.065, P = 0.022), being employed (r = −0.091, P = 0.002) and mobility (r = 0.138, P = 0.011).

When controlling for age and CVD, binary logistic regression analysis revealed that BMI (odds ratio [OR] = 1.026, P = 0.036) and being employed (OR = 0.617, P = 0.003) were independently associated with elevated pulse pressure (Table 1). The unique variance explained by BMI and being employed as predictor variables on pulse pressure was 11% (adjusted R2 = 0.11) and 16% (adjusted R2 = 0.162), respectively.

Table 1 Binary logistic regression with elevated pulse pressure (PP ≥ 60) as dependent variable

BMI, body mass index. Hosmer–Lemeshow test: χ2 = 2.182, P = 0.975.

The 343 patients with recorded WHODAS-2.0 were similar to patients without such recordings in terms of their age (mean 51.7 v. 52.4, t = −0.779, P = 0.436) and their sex composition (X2 = 0.037, P = 0.847).

Patients with elevated pulse pressure tended to have higher mean scores (more functional impairment) in all dimensions of functioning. However, only the dimensions of household (P = 0.043) and mobility (P = 0.001) were statistically significant, as was the WHODAS-2.0 sum score (P = 0.008) (Table 2).

Table 2 Differences in dimensions of functioning between patients with normal (<60) and elevated (≥60) pulse pressure (PP). Numbers represent mean (s.d.) and interquartile range

Cognition, understanding and communicating; Household, life activities; Mobility, getting around; Self-care, maintaining personal hygiene and dressing independently; Social, getting along with others; Society: participation in society.

a. Mann–Whitney U-test.

*P < 0.05, **P < 0.01.

Discussion

Similar to previous research in patients without psychiatric disorders, we found that elevated pulse pressure was related to patients’ physical health status indicators such as BMI and presence of diabetes, CVD and COPD.Reference Dart and Kingwell3 Elevated pulse pressure was particularly related to the physical dimensions of functioning such as mobility and ability to perform household chores. Unlike previous research, we did not find any statistically significant associations between elevated pulse pressure and cognitive impairments.Reference Morra and Strauss7

When controlling for age and CVD, we found that patients that were employed had a significantly lower OR for elevated pulse pressure (roughly a 40% reduction). This is consistent with research using cohorts from the general population, which also found that employment status was a significant predictor of elevated pulse pressure.Reference Matricciani, Paquet, Howard, Adams, Coffee and Taylor9 Interestingly, in our study, other aspects of socioeconomic status such as the patients’ education level and living situation were not significantly associated with pulse pressure. The clear association with elevated pulse pressure and being employed might therefore relate to functioning, as increased impairment in physical dimensions of functioning (e.g. mobility) and the sum disability score were associated with elevated pulse pressure, which in turn might explain the patient's ability to work. Another potential explanation for this association might be patients’ income, which we unfortunately did not have information about. Patients in employment tend to have better financial situations, and this might influence their opportunity to access treatment for hypertension and other medical conditions, as observed in previous studies.Reference Jung, Choi, Park, Jang and Park8,Reference Kim, Chung, Lim, Seo, Kim and Zo14

Blood pressure is regularly measured in psychiatric settings, and pulse pressure is easily calculated. It is therefore worth considering using pulse pressure more actively as a prognostic marker in clinical practice.Reference Yildiran, Koc, Bozkurt, Sahin, Unal and Acarturk15 These findings suggest that psychotic outpatients with high BMI and patients that are unemployed are the most at risk of elevated pulse pressure, which needs to be considered in clinical practice. A limitation of the current study was its cross-sectional design. Cross-sectional designs have inherent predictive constraints, because the temporal link between exposure and outcome cannot be established as both are examined at the same time. Thus, it is not possible to determine a true cause and effect relationship. Future studies should therefore consider using longitudinal designs. This would allow researchers to examine the predictive validity of pulse pressure more robustly in the identification of health status and functioning in patients with psychotic disorders. Another limitation of the current study was the potential for selection effects to influence the representativeness of the study sample. Of the 2179 patients that had an annual health check-up recorded, 1289 (59%) had complete blood pressure and BMI recordings obtained within the same 7 day period. This could mean that patients with more severe mental or physical disease or disability were not accurately represented in the sample. However, the sample was heterogenous in terms of demographic (e.g. wide age distribution) and clinical (e.g. wide BMI distribution) parameters, which reflects the clinical patient population.

Supplementary material

Supplementary material is available online at http://doi.org/10.1192/bjo.2022.52.

Data availability

Study data are not available for sharing owing to ethical approval requirements. Researchers interested in collaboration should contact the corresponding author.

Acknowledgements

We thank Torbjörn Jakobsson for assistance with data acquisition.

Author contributions

C.H. contributed to the design of the study, analysed the data, drafted the manuscript for publication, reviewed and revised the manuscript, and read and approved the final manuscript. A.G. and J.T. contributed to the design of the study, reviewed and revised the manuscript, and read and approved the final manuscript.

Funding

None.

Declaration of interest

None.

References

Nawrot, TS, Staessen, JA, Thijs, L, Fagard, RH, Tikhonoff, V, Wang, J-G, et al. Should pulse pressure become part of the framingham risk score? J Hum Hypertens 2004; 18(4): 279–86.CrossRefGoogle ScholarPubMed
Mansia, G, De Backer, G, Dominiczak, A, Cifkova, R, Fagard, R, Germano, G, et al. 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press 2007; 16(3): 135232.Google Scholar
Dart, AM, Kingwell, BA. Pulse pressure—a review of mechanisms and clinical relevance. J Am Coll Cardiol 2001; 37(4): 975–84.CrossRefGoogle ScholarPubMed
Thorin-Trescases, N, de Montgolfier, O, Pinçon, A, Raignault, A, Caland, L, Labbé, P, et al. Impact of pulse pressure on cerebrovascular events leading to age-related cognitive decline. Am J Physiol Heart Circ Physiol 2018; 314(6): H1214–24.CrossRefGoogle ScholarPubMed
Levin, RA, Carnegie, MH, Celermajer, DS. Pulse pressure: an emerging therapeutic target for dementia. Front Neurosci 2020; 14: 669.CrossRefGoogle ScholarPubMed
Fernandez-Egea, E, Bernardo, M, Heaphy, CM, Griffith, JK, Parellada, E, Esmatjes, E, et al. Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis. Schizophr Bull 2009; 35(2): 437–42.CrossRefGoogle ScholarPubMed
Morra, LF, Strauss, GP. Severity of hypertension predicts the generalized neurocognitive deficit in schizophrenia. Schizophr Res 2016; 176(2–3): 527–8.CrossRefGoogle Scholar
Jung, Y, Choi, D-W, Park, S, Jang, S-I, Park, E-C. Association between pulse pressure and onset of dementia in an elderly Korean population: a cohort study. Int J Environ Res Public Health 2020; 17(5): 1657.CrossRefGoogle Scholar
Matricciani, LA, Paquet, C, Howard, NJ, Adams, R, Coffee, NT, Taylor, AW, et al. Investigating individual- and area-level socioeconomic gradients of pulse pressure among normotensive and hypertensive participants. Int J Environ Res Public Health 2013; 10(2): 571–89.CrossRefGoogle ScholarPubMed
Vandenbroucke, JP, von Elm, E, Altman, DG, Gøtzsche, PC, Mulrow, CD, Pocock, SJ, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Epidemiology 2007; 18(6): 805–35.CrossRefGoogle ScholarPubMed
Holmberg, C, Gremyr, A, Torgerson, J, Mehlig, K. Clinical validity of the 12-item WHODAS-2.0 in a naturalistic sample of outpatients with psychotic disorders. BMC Psychiatry 2021; 21(1): 147.CrossRefGoogle Scholar
Üstün, TB, Chatterji, S, Kostanjsek, N, Rehm, J, Kennedy, C, Epping-Jordan, J, et al. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ 2010; 88(11): 815–23.CrossRefGoogle ScholarPubMed
Williams, B, Mancia, G, Spiering, W, Agabiti Rosei, E, Azizi, M, Burnier, M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J 2018; 39(33): 3021–104.CrossRefGoogle Scholar
Kim, H-L, Chung, J, Lim, W-H, Seo, J-B, Kim, S-H, Zo, J-H, et al. Association between household income and pulse pressure: data from the Korean national health and nutrition examination survey. Blood Press 2021; 30(4): 258–64.CrossRefGoogle ScholarPubMed
Yildiran, T, Koc, M, Bozkurt, A, Sahin, DY, Unal, I, Acarturk, E. Low pulse pressure as a predictor of death in patients with Mild to advanced heart failure. Tex Heart Inst J 2010; 37(3): 284–90.Google ScholarPubMed
Figure 0

Table 1 Binary logistic regression with elevated pulse pressure (PP ≥ 60) as dependent variable

Figure 1

Table 2 Differences in dimensions of functioning between patients with normal (<60) and elevated (≥60) pulse pressure (PP). Numbers represent mean (s.d.) and interquartile range

Supplementary material: File

Holmberg et al. supplementary material

Holmberg et al. supplementary material

Download Holmberg et al. supplementary material(File)
File 31.7 KB
Submit a response

eLetters

No eLetters have been published for this article.